YMAIF yields 3571.43% · PFE yields 6.13%● Live data
📍 YMAIF pulled ahead of the other in Year 1
Combined, YMAIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMAIF + PFE for your $10,000?
Yoma Strategic Holdings Ltd., an investment holding company, engages in the real estate, automotive and heavy equipment, consumer, financial, and investment businesses in Singapore, Myanmar, and the People's Republic of China. The company's Real Estate Development segment develops and sells land and properties. Its Real Estate Services segment provides project management, design, and estate management services, as well as property leasing services and operates golf estate. The company's Automotive & Heavy Equipment segment supplies and sells agriculture and construction equipment, passenger and commercial vehicles, and related parts, as well as offers maintenance services. Its Consumer segment engages in the operation of restaurants; bottling and distribution of beverages; food wholesale business; and provision of logistics services. The company's Financial Services segment provides vehicle financing; and invests in mobile financial services. Its Investments segment invests in the infrastructure, tourism, power agricultural, and other sectors, as well as leases investment properties. The company also engages in leasing automotive equipment. The company was formerly known as Sea View Hotel Limited. Yoma Strategic Holdings Ltd. was incorporated in 1962 and is based in Singapore.
Full YMAIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.